B cell responses to influenza infection and vaccination

Christopher Chiu, Ali H. Ellebedy, Jens Wrammert, Rafi Ahmed

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Abstract

Although vaccines against influenza are widely available, control of the disease remains elusive. In part, this is due to the inability of current vaccines to induce durable, broadly protective immune responses. Prevention of influenza depends primarily on effective antibody responses that block virus entry. Following infection, high-affinity IgA antibodies are generated in the respiratory tract that lead to immune exclusion, while IgG prevents systemic spread. These are effective and long-lasting but also exert immune pressure. Mutation of the antigenic determinants of influenza therefore rapidly leads to emergence of novel variants that evade previously generated protective responses. Not only do vaccines suffer from this strain-specific limitation, but also they are suboptimal in their ability to induce durable immunity. However, recent evidence has demonstrated the possibility of inducing broadly cross-reactive antibody responses. Further understanding of the ways in which high-titer, long-lived antibody responses directed against such cross-reactive epitopes can be induced would lead to the development of novel vaccines that may remove the requirement for recurrent vaccination.

Original languageEnglish
Pages (from-to)381-398
Number of pages18
JournalCurrent topics in microbiology and immunology
Volume386
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint Dive into the research topics of 'B cell responses to influenza infection and vaccination'. Together they form a unique fingerprint.

Cite this